Panagora Asset Management Inc Galera Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$7.04 - $10.49 $3,984 - $5,937	-566 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$6.08 - $10.44 $216,314 - $371,434	-35,578 Reduced 98.43%	566 $6,000
Q1 2021 May 12, 2021	BUY	$8.35 - $12.39 $20,148 - $29,897	2,413 Added 7.15%	36,144 $319,000
Q4 2020 Feb 10, 2021	BUY	$8.02 - $12.81 $264,996 - $423,268	33,042 Added 4795.65%	33,731 $345,000
Q3 2020 Nov 13, 2020	BUY	$6.96 - $9.12 $4,795 - $6,283	689 New	689 $6,000

909K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $1.07M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.